The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Finkelman, F. D.
Right arrow Articles by Maliszewski, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Finkelman, F. D.
Right arrow Articles by Maliszewski, C. R.

The Journal of Immunology, Vol 151, Issue 3 1235-1244, Copyright © 1993 by American Association of Immunologists

ARTICLES

Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes

FD Finkelman, KB Madden, SC Morris, JM Holmes, N Boiani, IM Katona and CR Maliszewski
Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814.

Anti-cytokine antibodies that block interactions between cytokines and cytokine receptors have been used to inhibit endogenous cytokine function. However, injection of mice with mixtures of IL-4 and either of two neutralizing anti-IL-4 mAb, at a cytokine/anti-cytokine mAb molar ratio of approximately 2:1, enhances and prolongs in vivo IL-4 activity, as measured by induction of increased spleen cell Ia expression. Although splenocyte Ia expression returns to baseline two days after mice are injected with free IL-4, soluble IL-4-anti-IL-4 mAb complexes still induce several-fold increases in Ia expression 3 days after injection. Complexes that contain as little as 400 ng of IL-4 have considerable in vivo stimulatory activity, and a maximal effect on splenocyte Ia expression is induced by injection of 2 micrograms of complexed IL-4. The stimulatory effect of IL-4-containing complexes on splenocyte Ia expression can be blocked by increasing the ratio of anti- IL-4 mAb to IL-4, by injection of anti-IL-4R mAb, and by in vivo aggregation of the complexes. Complexes of IL-4 with a non-neutralizing anti-IL-4 mAb do not have increased IL-4 agonist activity in vivo. These observations are most consistent with the possibility that neutralizing anti-IL-4 mAb act as carrier proteins that increase the in vivo half-life of IL-4 by preventing its excretion, and possibly, by preventing modification of its active site. The enhanced agonist effect of IL-4-anti-IL-4 mAb complexes is not unique; complexes of IL-3 with a neutralizing anti-IL-3 mAb have a greatly increased ability, compared with free IL-3, to stimulate mucosal mastocytosis, and complexes of IL- 7 with a neutralizing anti-IL-7 mAb have a greatly increased ability, compared with free IL-7 or IL-7 complexed with a non-neutralizing anti- IL-7 mAb, to stimulate an increase in pre-B cell number. These observations suggest that complexes of cytokines and neutralizing anti- cytokine mAb may provide a generally useful way to increase the magnitude and duration of cytokine effects in vivo.


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
M. T. Kasaian, X.-Y. Tan, M. Jin, L. Fitz, K. Marquette, N. Wood, T. A. Cook, J. Lee, A. Widom, R. Agostinelli, et al.
Interleukin-13 Neutralization by Two Distinct Receptor Blocking Mechanisms Reduces Immunoglobulin E Responses and Lung Inflammation in Cynomolgus Monkeys
J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 882 - 892.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
O. Boyman, C. Ramsey, D. M. Kim, J. Sprent, and C. D. Surh
IL-7/Anti-IL-7 mAb Complexes Restore T Cell Development and Induce Homeostatic T Cell Expansion without Lymphopenia
J. Immunol., June 1, 2008; 180(11): 7265 - 7275.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Munitz, E. B. Brandt, M. Mingler, F. D. Finkelman, and M. E. Rothenberg
Distinct roles for IL-13 and IL-4 via IL-13 receptor {alpha}1 and the type II IL-4 receptor in asthma pathogenesis
PNAS, May 20, 2008; 105(20): 7240 - 7245.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Mostbock, M. E. C. Lutsiak, D. E. Milenic, K. Baidoo, J. Schlom, and H. Sabzevari
IL-2/Anti-IL-2 Antibody Complex Enhances Vaccine-Mediated Antigen-Specific CD8+ T Cell Responses and Increases the Ratio of Effector/Memory CD8+ T Cells to Regulatory T Cells
J. Immunol., April 1, 2008; 180(7): 5118 - 5129.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. D. Phelan, T. Orekov, and F. D. Finkelman
Cutting Edge: Mechanism of Enhancement of In Vivo Cytokine Effects by Anti-Cytokine Monoclonal Antibodies
J. Immunol., January 1, 2008; 180(1): 44 - 48.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
U. Sriram, C. Biswas, E. M. Behrens, J.-A. Dinnall, D. K. Shivers, M. Monestier, Y. Argon, and S. Gallucci
IL-4 Suppresses Dendritic Cell Response to Type I Interferons
J. Immunol., November 15, 2007; 179(10): 6446 - 6455.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
D. Kamimura and M. J. Bevan
Naive CD8+ T cells differentiate into protective memory-like cells after IL-2 anti IL-2 complex treatment in vivo
J. Exp. Med., August 6, 2007; 204(8): 1803 - 1812.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Tripathi, T. C. Mitchell, F. Finkelman, and D. A. Hildeman
Cutting Edge: Limiting Amounts of IL-7 Do Not Control Contraction of CD4+ T Cell Responses
J. Immunol., April 1, 2007; 178(7): 4027 - 4031.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
J.-Y. Lu, N. Sadri, and R. J. Schneider
Endotoxic shock in AUF1 knockout mice mediated by failure to degrade proinflammatory cytokine mRNAs
Genes & Dev., November 15, 2006; 20(22): 3174 - 3184.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Munitz, I. Bachelet, R. Eliashar, M. Khodoun, F. D. Finkelman, M. E. Rothenberg, and F. Levi-Schaffer
CD48 Is an Allergen and IL-3-Induced Activation Molecule on Eosinophils
J. Immunol., July 1, 2006; 177(1): 77 - 83.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Kamimura, Y. Sawa, M. Sato, E. Agung, T. Hirano, and M. Murakami
IL-2 In Vivo Activities and Antitumor Efficacy Enhanced by an Anti-IL-2 mAb
J. Immunol., July 1, 2006; 177(1): 306 - 314.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A.-L. Andrews, J. W. Holloway, S. T. Holgate, and D. E. Davies
IL-4 Receptor {alpha} Is an Important Modulator of IL-4 and IL-13 Receptor Binding: Implications for the Development of Therapeutic Targets.
J. Immunol., June 15, 2006; 176(12): 7456 - 7461.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. P. Rubinstein, M. Kovar, J. F. Purton, J.-H. Cho, O. Boyman, C. D. Surh, and J. Sprent
Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}
PNAS, June 13, 2006; 103(24): 9166 - 9171.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. C. Morris, T. Orekhova, M. J. Meadows, S. M. Heidorn, J. Yang, and F. D. Finkelman
IL-4 Induces In Vivo Production of IFN-{gamma} by NK and NKT Cells
J. Immunol., May 1, 2006; 176(9): 5299 - 5305.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
O. Boyman, M. Kovar, M. P. Rubinstein, C. D. Surh, and J. Sprent
Selective Stimulation of T Cell Subsets with Antibody-Cytokine Immune Complexes
Science, March 31, 2006; 311(5769): 1924 - 1927.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Minami, Y. Yanagawa, K. Iwabuchi, N. Shinohara, T. Harabayashi, K. Nonomura, and K. Onoe
Negative feedback regulation of T helper type 1 (Th1)/Th2 cytokine balance via dendritic cell and natural killer T cell interactions
Blood, September 1, 2005; 106(5): 1685 - 1693.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
F. D. Finkelman, M. Yang, C. Perkins, K. Schleifer, A. Sproles, J. Santeliz, J. A. Bernstein, M. E. Rothenberg, S. C. Morris, and M. Wills-Karp
Suppressive Effect of IL-4 on IL-13-Induced Genes in Mouse Lung
J. Immunol., April 15, 2005; 174(8): 4630 - 4638.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. E. O'Hear and J. Foote
Antibody buffering of a ligand in vivo
PNAS, January 4, 2005; 102(1): 40 - 44.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
M. V. Khodoun, T. Orekhova, C. Potter, S. Morris, and F. D. Finkelman
Basophils Initiate IL-4 Production during a Memory T-dependent Response
J. Exp. Med., October 4, 2004; 200(7): 857 - 870.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
N. E. King, N. Zimmermann, S. M. Pope, P. C. Fulkerson, N. M. Nikolaidis, A. Mishra, D. P. Witte, and M. E. Rothenberg
Expression and Regulation of a Disintegrin and Metalloproteinase (ADAM) 8 in Experimental Asthma
Am. J. Respir. Cell Mol. Biol., September 1, 2004; 31(3): 257 - 265.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. R. Mathers and C. F. Cuff
Role of Interleukin-4 (IL-4) and IL-10 in Serum Immunoglobulin G Antibody Responses following Mucosal or Systemic Reovirus Infection
J. Virol., April 1, 2004; 78(7): 3352 - 3360.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
N. M. Nikolaidis, N. Zimmermann, N. E. King, A. Mishra, S. M. Pope, F. D. Finkelman, and M. E. Rothenberg
Trefoil Factor-2 Is an Allergen-Induced Gene Regulated by Th2 Cytokines and STAT6 in the Lung
Am. J. Respir. Cell Mol. Biol., October 1, 2003; 29(4): 458 - 464.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Zhao, J. McDermott, J. F. Urban Jr, W. Gause, K. B. Madden, K. A. Yeung, S. C. Morris, F. D. Finkelman, and T. Shea-Donohue
Dependence of IL-4, IL-13, and Nematode-Induced Alterations in Murine Small Intestinal Smooth Muscle Contractility on Stat6 and Enteric Nerves
J. Immunol., July 15, 2003; 171(2): 948 - 954.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. T. Strait, S. C. Morris, K. Smiley, J. F. Urban Jr., and F. D. Finkelman
IL-4 Exacerbates Anaphylaxis
J. Immunol., April 1, 2003; 170(7): 3835 - 3842.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
M. G. Chiaramonte, M. Mentink-Kane, B. A. Jacobson, A. W. Cheever, M. J. Whitters, M. E.P. Goad, A. Wong, M. Collins, D. D. Donaldson, M. J. Grusby, et al.
Regulation and Function of the Interleukin 13 Receptor {alpha} 2 During a T Helper Cell Type 2-dominant Immune Response
J. Exp. Med., March 17, 2003; 197(6): 687 - 701.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
J. H. Von der Thusen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen
Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential
Pharmacol. Rev., March 1, 2003; 55(1): 133 - 166.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. B. Madden, L. Whitman, C. Sullivan, W. C. Gause, J. F. Urban Jr., I. M. Katona, F. D. Finkelman, and T. Shea-Donohue
Role of STAT6 and Mast Cells in IL-4- and IL-13-Induced Alterations in Murine Intestinal Epithelial Cell Function
J. Immunol., October 15, 2002; 169(8): 4417 - 4422.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. C. Morris, N. L. Dragula, and F. D. Finkelman
IL-4 Promotes Stat6-Dependent Survival of Autoreactive B Cells In Vivo Without Inducing Autoantibody Production
J. Immunol., August 15, 2002; 169(4): 1696 - 1704.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
R. Venkayya, M. Lam, M. Willkom, G. Grunig, D. B. Corry, and D. J. Erle
The Th2 Lymphocyte Products IL-4 and IL-13 Rapidly Induce Airway Hyperresponsiveness Through Direct Effects on Resident Airway Cells
Am. J. Respir. Cell Mol. Biol., February 1, 2002; 26(2): 202 - 208.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Y. Karulin, M. D. Hesse, H. C. Yip, and P. V. Lehmann
Indirect IL-4 Pathway in Type 1 Immunity
J. Immunol., January 15, 2002; 168(2): 545 - 553.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. F. Urban Jr., N. Noben-Trauth, L. Schopf, K. B. Madden, and F. D. Finkelman
Cutting Edge: IL-4 Receptor Expression by Non-Bone Marrow-Derived Cells Is Required to Expel Gastrointestinal Nematode Parasites
J. Immunol., December 1, 2001; 167(11): 6078 - 6081.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Shea-Donohue, C. Sullivan, F. D. Finkelman, K. B. Madden, S. C. Morris, J. Goldhill, V. Pineiro-Carrero, and J. F. Urban Jr.
The Role of IL-4 in Heligmosomoides polygyrus-Induced Alterations in Murine Intestinal Epithelial Cell Function
J. Immunol., August 15, 2001; 167(4): 2234 - 2239.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J.C. Kips, K.G. Tournoy, and R.A. Pauwels
New anti-asthma therapies: suppression of the effect of interleukin (IL)-4 and IL-5
Eur. Respir. J., March 1, 2001; 17(3): 499 - 506.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. KURDOWSKA, J. M. NOBLE, K. P. STEINBERG, J. T. RUZINSKI, L. D. HUDSON, and T. R. MARTIN
Anti-interleukin 8 Autoantibody:Interleukin 8 Complexes in the Acute Respiratory Distress Syndrome . Relationship between the Complexes and Clinical Disease Activity
Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 463 - 468.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
M. Mori, S. C. Morris, T. Orekhova, M. Marinaro, E. Giannini, and F. D. Finkelman
IL-4 Promotes the Migration of Circulating B Cells to the Spleen and Increases Splenic B Cell Survival
J. Immunol., June 1, 2000; 164(11): 5704 - 5712.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
I. A. Abrahamsohn, A. P. G. da Silva, and R. L. Coffman
Effects of Interleukin-4 Deprivation and Treatment on Resistance to Trypanosoma cruzi
Infect. Immun., April 1, 2000; 68(4): 1975 - 1979.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. C. Morris, W. C. Gause, and F. D. Finkelman
IL-4 Suppression of In Vivo T Cell Activation and Antibody Production
J. Immunol., February 15, 2000; 164(4): 1734 - 1740.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. F. Urban Jr., L. Schopf, S. C. Morris, T. Orekhova, K. B. Madden, C. J. Betts, H. R. Gamble, C. Byrd, D. Donaldson, K. Else, et al.
Stat6 Signaling Promotes Protective Immunity Against Trichinella spiralis Through a Mast Cell- and T Cell-Dependent Mechanism
J. Immunol., February 15, 2000; 164(4): 2046 - 2052.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
F. D. Finkelman and S. C. Morris
Development of an assay to measure in vivo cytokine production in the mouse
Int. Immunol., November 1, 1999; 11(11): 1811 - 1818.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Itoh-Lindstrom, J. F. Piskurich, N. J. Felix, Y. Wang, W. J. Brickey, J. L. Platt, B. H. Koller, and J. P.-Y. Ting
Reduced IL-4-, Lipopolysaccharide-, and IFN-{gamma}-Induced MHC Class II Expression in Mice Lacking Class II Transactivator Due to Targeted Deletion of the GTP-Binding Domain
J. Immunol., September 1, 1999; 163(5): 2425 - 2431.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
K. Hung, R. Hayashi, A. Lafond-Walker, C. Lowenstein, D. Pardoll, and H. Levitsky
The Central Role of CD4+ T Cells in the Antitumor Immune Response
J. Exp. Med., December 21, 1998; 188(12): 2357 - 2368.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
H. Faulkner, J.-C. Renauld, J. Van Snick, and R. K. Grencis
Interleukin-9 Enhances Resistance to the Intestinal Nematode Trichuris muris
Infect. Immun., August 1, 1998; 66(8): 3832 - 3840.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. D. Punch, T. Tono, L. Qin, D. K. Bishop, and J. S. Bromberg
Tolerance Induction by Anti-CD2 Plus Anti-CD3 Monoclonal Antibodies: Evidence for an IL-4 Requirement
J. Immunol., August 1, 1998; 161(3): 1156 - 1162.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
C. Zuany-Amorim, C. Ruffié, S. Hailé, B. B. Vargaftig, P. Pereira, and M. Pretolani
Requirement for gammadelta T cells in allergic airway inflammation.
Science, May 22, 1998; 280(5367): 1265 - 1267.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
S. M. Grunewald, A. Werthmann, B. Schnarr, C. E. Klein, E. B. Brocker, M. Mohrs, F. Brombacher, W. Sebald, and A. Duschl
An Antagonistic IL-4 Mutant Prevents Type I Allergy in the Mouse: Inhibition of the IL-4/IL-13 Receptor System Completely Abrogates Humoral Immune Response to Allergen and Development of Allergic Symptoms In Vivo
J. Immunol., April 15, 1998; 160(8): 4004 - 4009.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
H. W. Murray, J. Hariprashad, and R. L. Coffman
Behavior of  Visceral Leishmania donovani in an Experimentally Induced T Helper Cell 2 (Th2)-Associated Response Model
J. Exp. Med., March 3, 1997; 185(5): 867 - 874.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
T. Yoshimoto, A. Bendelac, C. Watson, J. Hu-Li, and W. E. Paul
Role of NK1.1+ T Cells in a TH2 Response and in Immunoglobulin E Production
Science, December 15, 1995; 270(5243): 1845 - 1847.
[Abstract] [PDF]

Home page
 LupusHome page
M. Evans and N. I. Abdou
Anti-Interleukin-6 and Soluble Interleukin-6 Receptor in Systemic Lupus Erythematosus
Lupus, June 1, 1994; 3(3): 161 - 166.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.